Transactions and Operations for the Life Sciences CFO

Life Sciences Executive Series

The CFO series is designed to provide quick access to critical industry trends and issues CFOs face. Click the link below to access the most recent research. This page will be updated with additional content as new data becomes available.

Explore content

M&A drives shareholder value for life sciences

Key takeaway

As CFOs of life sciences companies are increasingly expected to participate in shareholder value creation, they should consider broadening their role in driving corporate strategy, including creative approaches to mergers, acquisitions, and restructurings.

Back to LS Executive Series

Did you find this useful?